show episodes
 
Artwork

1
Superbugs Unplugged

Lance Price and Jay Graham

Unsubscribe
Unsubscribe
Monthly
 
A joint project of Antibiotic Resistance Action Center, Milken Institute School of Public Health at the George Washington University and the UC Berkeley School of Public Health, this monthly podcast will delve into the critical health threat of antibiotic resistance and what drives it, including antibiotic use in agriculture and human health care, challenges and opportunities in R&D, and more. Co-hosts Dr. Lance Price and Dr. Jau Graham will cover a new topic and feature an expert guest ever ...
  continue reading
 
Artwork

1
ESG now

MSCI ESG Research LLC

Unsubscribe
Unsubscribe
Monthly+
 
Environmental, social, and governance (ESG) news and investment research brought to you weekly covering major market trends and new research insights. With topics ranging from climate impact on investment portfolios, corporate actions, trending investment topics, and emerging ESG issues, hosts Mike Disabato and Bentley Kaplan of MSCI ESG Research walk through the latest news and research that is top of mind for the week.
  continue reading
 
Artwork

1
Future Hacker (English)

Future Hacker English

Unsubscribe
Unsubscribe
Monthly
 
Future Hacker is an invitation to embark on a journey into the future exploring new paths, new discoveries, new thoughts, and debates that should become reality in 10, 20 and 30 years. Renowned national and international professionals will discuss topics such as Singularity, Immersive Experiences, Artificial Intelligence, Clean Energy, Circular Economy, Genomic Medicine, the Future of Education, Silicon Humanism, Crypto Economy, and several related topics.
  continue reading
 
One World, One Health is brought to you by the One Health Trust. In this podcast, we bring you the latest ideas to improve the health of our planet and its people. Our world faces many urgent challenges from pandemics and decreasing biodiversity to pollution and melting polar ice caps, among others. This podcast highlights solutions to these problems from the scientists and experts working to make a difference.
  continue reading
 
Artwork

1
RE: Engineering Radio

Michigan Engineering

Unsubscribe
Unsubscribe
Monthly
 
Engineering begins and ends with people. Michigan Engineers strive to foster a people-first approach to close critical gaps and elevate all people. RE: Engineering Radio is a podcast from Michigan Engineering, sharing stories about research that builds and rebuilds systems — and the people who make it happen. Hosted on Acast. See acast.com/privacy for more information.
  continue reading
 
The impact of modern medicine on the human condition can’t be underestimated. From antibiotics to vaccines, medicine has changed the way our bodies work, answered deadly questions, and promised faster cures. But it’s not simple. Drug development is rife with tension. It costs a lot of money, and takes a long time. Most things fail. But when they succeed, they can make a tremendous difference in people’s lives. Where will the next breakthroughs come from? How will we pay for them? Who decides ...
  continue reading
 
RCSI MyHealth provides a trusted and accessible source of information on health and well-being. The series covers health and well-being topics of broad interest to patients, their families and the wider public. Access to accurate health information is an important resource to empower people with the tools to maintain good health and well-being. The lecture series is open to those who want to learn more about common illnesses and health-related topics directly from healthcare experts. The ser ...
  continue reading
 
Loading …
show series
 
Antimicrobial resistance is getting worse. Set to impact healthcare, agriculture and insurance, it’s a phenomenon worth paying attention to. On this episode, we take a look at whether there’s an investment case for fighting back against the superbugs. Host: Bentley Kaplan, MSCI ESG Research Guest: Namita Nair, MSCI ESG Research…
  continue reading
 
Dr. Nour Shamas knows about antimicrobial resistance. As a clinical pharmacist, she was trained in how to dispense drugs to treat infections, and her graduate studies in global health policy made her aware of the threat of antimicrobial resistance, or AMR. Antimicrobial resistance develops when bacteria, viruses, fungi, or parasites evolve the abil…
  continue reading
 
We periodically put out this report called the Net-Zero Tracker, and it examines the progress by the world’s listed companies toward curbing climate risk. This episode is a dive into the most important bits of our most recently published report. Link to the Net-Zero Tracker: The MSCI Sustainability Institute Net-Zero Tracker Host: Mike Disabato, MS…
  continue reading
 
Urinary tract infections (UTIs) are common, uncomfortable, and embarrassing. They can also be deadly. These infections of the kidneys, bladder, or urethra affect about 1 in 10 men in their lifetimes and more than half of women. Untreated UTIs can cause a body-wide infection known as sepsis. An estimated 236,000 people globally die every year from U…
  continue reading
 
Join us in this exciting episode as we sit down with Rodrigo Griesi, a modern-day Indiana Jones of the seas! With a rich background in consulting, logistics, project management, marketing, sales, and power generation, Rodrigo is now venturing into entrepreneurship and captaining his latest venture, Neptunya Ocean Power. He has found his Ikigai by d…
  continue reading
 
The social pillar has often been maligned as the ignored sibling of the ESG acronym. In its essence, the social pillar is a measurement of how a company, its employees, its products, and the community it operates in are supported and often challenged. For this episode, we show you why that all matters for measuring a company’s market performance. H…
  continue reading
 
It’s early days for sustainability-linked bonds, where issuers see their interest rates rise after missing sustainability targets. But instead of throwing in the towel after some initial setbacks, we talk about companies that have doubled down on their sustainability commitments. Host: Bentley Kaplan, MSCI ESG Research Guest: Guilherme de Melo Silv…
  continue reading
 
Good governance is foundational to effective capital markets, promoting accountability, transparency and sound decision-making aligned with investor interests. But how do those potential benefits translate into market performance? Well today, we answer that question for you! We answer the question: does governance even matter. If you want to read t…
  continue reading
 
Guinea worm infections have been plaguing mankind throughout recorded history. The Carter Center took the lead in the guinea worm eradication effort in the 1980’s, when there were over 3 million cases per year. Through concentrated effort, this disease is on the brink of extinction, with only 14 human cases in 2023! Adam Weiss, MPH, is the director…
  continue reading
 
Data from over 4,000 issuers, spanning nearly a decade revealed that companies with better MSCI ESG Ratings tended to have a lower cost of capital. It’s big news for investors and another step towards understanding the relationship between sustainability and financial performance. Host: Bentley Kaplan, MSCI ESG Research Guests: Jakub Malich & Anett…
  continue reading
 
Join us in this exciting episode as we sit down with Rodrigo Griesi, a modern-day Indiana Jones of the seas! With a rich background in consulting, logistics, project management, marketing, sales, and power generation, Rodrigo is now venturing into entrepreneurship and captaining his latest venture, Neptunya Ocean Power. He has found his Ikigai by d…
  continue reading
 
No one wants to be exposed to air pollution. No one wants to raise their kids breathing in polluted air in their own neighborhoods. But in Austin, Texas, people of color are disproportionately forced to do both. Dr. Sarah Chambliss, a research associate in the Department of Population Health at Dell Medical School at the University of Texas at Aust…
  continue reading
 
Our demand for electricity is growing for the first time in decades. Nuclear energy is being proffered as the answer to our voracious energy-appetites. But are investors capable of propping up an industry with so much complexity and risk? This episode provides an answer. Host: Michael Disabato, MSCI ESG Research Guest: Elchin Mammadov, MSCI ESG Res…
  continue reading
 
People don’t want to see any more pandemics, notes Nita Madhav, Senior Director of Epidemiology & Modeling at Ginkgo Biosecurity, the biosecurity and public health unit of Ginkgo Bioworks. The world is collectively traumatized by the horrors of the COVID-19 pandemic, Madhav says in this episode of One World, One Health. But just because we don’t wa…
  continue reading
 
What is impact materiality, you ask? And how is it different from financial materiality? A fine and important question, listener! In this episode we take you through all the details you need to parse through the most important sustainability-jargon out there. Including, an explanation of the EU's Corporate Sustainability Reporting Directive, or the…
  continue reading
 
Drug-resistant bacteria are major killers, playing a role in killing five million people a year. Antibiotics were miracle drugs when they were invented 100 years ago, but they are losing their power against always adapting and evolving bacteria. At the same time, the market for new antimicrobial drugs has collapsed. Hardly anyone wants to make new …
  continue reading
 
When it comes to climate altering carbon emissions, investors, like asset managers and banks, used to only measure their direct carbon emissions from their buildings and purchased electricity. But now, they are being asked by regulators, stakeholders, and clients to report on the emissions associated with their investment portfolios – a much more c…
  continue reading
 
An estimated 7.7 million people die from bacterial infections a year around the world. A growing number of these deaths are caused by bacteria that have developed antibiotic resistance – the ability to thrive in the face of antibiotics. This ability of germs to defy the effects of drugs is called antimicrobial resistance, or AMR. But why wait to tr…
  continue reading
 
They may not be new, but climate funds have recently hit their stride. From managing transition risk, to targeting technology opportunities, to aligning with the Paris agreement – these funds come in all shapes and sizes and with pretty diverse objectives. On this episode we catch you up on where climate funds stand today, and how differently they’…
  continue reading
 
In this episode, we sit down with Neil Redding, a visionary thinker and strategist renowned for his insights into the future of technology and society. Neil shares his journey from the early days of the internet to his current work in envisioning and shaping future experiences. We examine the intersections of technology, culture, and human behavior…
  continue reading
 
The problem of antimicrobial resistance – AMR for short – is clear. More and more of these germs resistant to existing treatments are emerging everywhere, and there’s little disagreement that governments, nonprofits, doctors, patients, and politicians all need to help tackle the problem. But people need to agree on what to do, and they need to agre…
  continue reading
 
What kills more people than HIV or malaria? What threatens anybody on the planet – and not just people, but animals, too? It’s antimicrobial resistance (AMR), the formal name for drug-resistant superbugs. These include bacteria that defy the effects of antibiotics, viruses that thrive in the face of antiviral drugs, and fungi that are immune to ant…
  continue reading
 
Maybe a rose by any other name would smell as sweet, but that’s not going to fly for sustainability funds in the EU. On this episode we break down ESMA’s latest fund guidelines and discuss their place in a regulatory landscape with all kinds of moving pieces. Host: Bentley Kaplan, MSCI ESG Research Guests: Meggin Eastman & Simone Ruiz-Vergote, MSCI…
  continue reading
 
Airlines are part of a hard to abate industry for a reason as there is not one straightforward path to decarbonization. In this episode, we discuss the options that airlines have to reduce their direct emissions in the coming decades – and we tell you which ones are more likely to be more viable. Host: Gabriela de la Serna, MSCI ESG Research Guest:…
  continue reading
 
Step into the remarkable journey of João Pacífico, founder and CEO of Grupo Gaia. This engaging conversation explores how business, activism, and the pursuit of happiness converge to create a positive impact in today’s fast-paced world. Join us as João shares his transformative experiences, from the challenges of starting his own company to his pas…
  continue reading
 
The second wave of the COVID-19 pandemic was especially bad in India. Patients filled hospitals as the Delta variant swept the country in April of 2021. As many as 2,000 people died every day. Many died literally gasping for air. Although India is a major producer of medical oxygen, supplies ran out amid the unprecedented demand. And while some are…
  continue reading
 
Alcoholic beverage companies are trying to navigate through a changing world, one where tastes are evolving, and resources are getting scarcer. In this episode, delve into the significant challenges and innovative strategies the alcoholic beverage industry is employing to combat this shift in drinking trends. Host: Michael Disabato, MSCI ESG Resear…
  continue reading
 
Antibiotic resistant bacteria are threatening modern society by making antibiotics obsolete. Dr. Nizet is a Professor and Vice Chair in the Department of Pediatrics at UCSD, as well as the faculty lead for the UCSD Collaborative to Halt Antibiotic-Resistant Microbes (CHARM). His laboratory studies how the human immune system interacts with microbia…
  continue reading
 
Vaccines save lives. There’s no doubt about this: childhood vaccination saves four million lives every year, the US Centers for Disease Control and Prevention says. Children worldwide get a long list of vaccines, but what about adults? A study by the Office of Health Economics (OHE), an independent research organization, took a look at the cost-eff…
  continue reading
 
Everyone is talking about AI, but on today’s episode we focus on the technology’s potential to disrupt health care. Then, we switch things up to look at how wildfires are exacerbating physical, legal and financial risks for electric utilities in the U.S. Host: Gabriela de la Serna, MSCI ESG Research Guests: Namita Nair & Mathew Lee, MSCI ESG Resear…
  continue reading
 
Bird flu – aka avian influenza – is doing what it does best yet again – surprising scientists, public health officials, farmers, and wildlife experts. It’s been spreading among dairy cattle in the United States, something that startles even long-term observers of the virus. The H5N1 strain of avian influenza was first noticed in the late 1990s and …
  continue reading
 
Coal still makes up a big cut of China’s energy mix. But the country’s growth in renewables is undeniable. As climate targets are laid down and climate change accelerates, figuring out China’s emissions trajectory is tricky. And that’s OK – we love a tricky discussion. Host: SK Kim, MSCI ESG Research Guests: Cody Dong & Siyao He, MSCI ESG Research…
  continue reading
 
In this inspiring episode, we sit down with Elham Youssefian, a visionary in the realms of disability rights and climate advocacy. Born blind in Iran, Elham recounts her journey overcoming educational barriers, supported by her family and vital braille resources, to becoming a human rights lawyer. She explains the essence of disability-inclusive em…
  continue reading
 
Coral reefs are literally the foundation for much of the life on Earth. These living cities are made up of animals –coral – which exist in symbiosis with algae. They are home to thousands of species of fish, as well as important to the lives of as many as a billion people who rely on their production of food, their protection of coastal areas, and …
  continue reading
 
For some investors, having a climate-savvy director on a company’s board may seem like a non-negotiable. But data from some of the world’s biggest greenhouse gas emitters shows that successful climate governance is complex and may require more than pinning all your hopes on a climate superstar. Host: Bentley Kaplan, MSCI ESG Research Guest: Florian…
  continue reading
 
From the moment people discovered how to use penicillin, the first antibiotic, resistance has been a problem. Bacteria may be small, but they are not simple organisms and they have been fighting for survival for billions of years. Many bacteria have developed the tools they need to evade the effects of antibiotic treatments, and they can trade thes…
  continue reading
 
This week we provide an update to our March 2022 episode titled Children in the Cocoa Field that explored the growing problem of child labor in cocoa harvesting. And the attempt by Nestlé to use money and enhanced mapping technology to combat its prevalence. It sounds bleak, but it was a great story about how technology is allowing for better trans…
  continue reading
 
It’s hotter and wetter than usual in Brazil, and climate conditions are driving an early blast of a killer virus – dengue. The mosquito-borne virus is spreading earlier than ever before and affecting far more parts of the country than usual – and all at once. Dengue’s a nasty virus. It causes pain so severe that it’s sometimes called breakbone feve…
  continue reading
 
Plastic is an inescapable reality of the modern world. But trading off its convenience and versatility for environmental and health impacts is getting harder. Companies that make or rely on plastic are being pushed to improve recyclability and reuse. And as tempting as it is to believe everything you read on a label, it looks like the road to a gen…
  continue reading
 
As part of this discussion, the panel will raise awareness around the key risk factors for heart health, in particular, how menopause affects women’s risk of heart disease and stroke, the role of lifestyle medicine in prevention and specific supports available around maintaining cardiac health and preventing cardiovascular disease. This episode wil…
  continue reading
 
The SEC’s climate disclosure rule is finally here. It’s been a journey, one akin to a film drama full of plot twists, cliff hangers and edge of the seat moments. So in honor of the drama, this week we do a film review of sorts on this wide reaching regulation - going into the plot, the actors involved, and how the industry is likely to be affected …
  continue reading
 
In this engaging episode we explore the intriguing world of immunology with our guest Liliana Moura Massis, a leading Scientist in autoimmune diseases. Liliana recounts her inspiring journey from Brazil to Silicon Valley, facing challenges and seizing opportunities in the biomedical sciences. She reflects on the brain drain from Brazil, offers advi…
  continue reading
 
Peggy Lillis wasn’t expecting trouble when her dentist prescribed antibiotics after she had a root canal in 2010. It was a standard, just-in-case treatment to prevent infections after the procedure. She also wasn’t worried when she developed diarrhea soon afterward. The kindergarten teacher assumed she’d caught a bug from one of her young students.…
  continue reading
 
Houston, we definitely do NOT have a problem…with interviewing Dr. Kate Rubins, NASA astronaut. Dr. Rubins is a virologist who has spent over 300 days in space, performing experiments aboard the International Space Station, where she was the first person to sequence DNA in space. We caught up with Dr. Rubins at the Neutral Buoyancy Lab in Houston, …
  continue reading
 
We have been reporting on board’s gender diversity since 2009, and while progress has undoubtedly been made, the road ahead is still long. Linda-Eling Lee from MSCI’s Sustainability Institute tells us why we started compiling this report in the first place, and how it has managed to remain relevant in 2024. Then, our colleague Christina Milhomem te…
  continue reading
 
There’s a virus that infects just about every adult. It’s passed by skin-to-skin contact – most often during sexual intercourse. It’s the human papillomavirus (HPV for short). It often doesn't show any symptoms, and at times the infection resolves on its own. It can cause warts, but more ominously, HPV is the single biggest cause of cervical cancer…
  continue reading
 
As part of this discussion, the panel will address the key concerns and worries that parents have around the topic of child nutrition and provide information and practical advice to support healthy growth and development. This episode will be chaired by Professor Oran D. Kennedy, Associate Professor, Department of Anatomy and Regenerative Medicine,…
  continue reading
 
The world acted as if the COVID-19 pandemic was a big surprise. However, just months before, the Global Preparedness Monitoring Board (GPMB) had warned that the world was vulnerable to a pandemic of respiratory illness and needed to act quickly. Kolinda Grabar-Kitarović, the former president of Croatia, says she felt frustrated and helpless when th…
  continue reading
 
ExxonMobil filed a legal complaint against two of its own shareholders, who were hoping to put a climate-related proposal to a vote at the company’s upcoming AGM. We discuss why it’s a decision that could have consequences for the wider shareholder community and the companies they invest in. Host: Bentley Kaplan, MSCI ESG Research Guest: Harlan Tuf…
  continue reading
 
Drug-resistant infections are a problem for everyone, but especially for newborns. They don’t have fully developed immune systems, and their bodies are less equipped to fight infections. The risk is highest for infants born sick or prematurely. Bloodborne infections – sepsis – are one major threat to newborns. Sepsis can move quickly, overpowering …
  continue reading
 
Loading …

Quick Reference Guide